Chrome Extension
WeChat Mini Program
Use on ChatGLM

Expression and Purification of BsaXI Restriction Endonuclease and Engineering New Specificity from BsaXI Specificity (S) Subunit

biorxiv(2022)

Cited 1|Views6
No score
Abstract
BsaXI is a Type IIB restriction endonuclease (REase) that cleaves both sides of its recognition sequence 5’ ↓N9 AC N5 CTCC N10↓ 3’ (complement strand 5’ ↓N7 GGAG N5 GT N12↓ 3’), creating 3-base 3’ overhangs. Here we report the cloning and expression of bsaXIS and bsaXIRM genes in E. coli . BsaXI activity was successfully reconstituted by mixing the BsaXI RM fusion subunit with the BsaXI S subunit and the enzyme complex further purified by chromatography over 6 columns. As expected, the S subunit consisted of two subdomains encoding TRD1-CR1 (TRD, target recognition domain, CR, conserved region) for 5’ AC 3’, and TRD2-CR2 presumably specifying 5’ CTCC 3’. TRD1-CR1 (TRD2-CR2 deletion) or duplication of TRD1 (TRD1-CR1-TRD1-CR2) both generated a new specificity 5’ AC N5 GT 3’ when the S variants were complexed with the RM subunits. Circular permutation of TRD1 and TRD2, i.e. relocation of TRD2-CR2 to the N-terminus and TRD1-CR1 to the C-terminus generated the same specificity with the RM subunits, although some wobble cleavage was detected. The TRD2 domain in the BsaXI S subunit can be substituted by a close homolog (∼59% sequence identity) and generated the same specificity. However, TRD2-CR2 domain alone failed to express in E. coli , but CR1-TRD2-CR2 protein could be expressed and purified which showed partial nicking activity with the RM subunits. This work demonstrated that like Type I restriction systems, the S subunit of a Type IIB system could also be manipulated to create new specificities. Genome mining of BsaXI TRD2 homologs in GenBank found more than 36 orphan TRD2 homologs, implying that quite a few orphan TRD2s are present in microbial genomes that may be potentially paired with other TRDs to create new restriction specificities. ### Competing Interest Statement Daniel Heiter and Shuang-yong Xu are employees of New England Biolabs, Inc., a company that develops restriction enzymes and other reagents for research and diagnostic applications.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined